Surgical Complexity and Outcome of Patients Undergoing Re-do Aortic Valve Surgery.
Adult
Aged
Aged, 80 and over
Aortic Valve
/ diagnostic imaging
Aortic Valve Insufficiency
/ diagnostic imaging
Aortic Valve Stenosis
/ diagnostic imaging
Bioprosthesis
Female
Heart Valve Prosthesis
Heart Valve Prosthesis Implantation
/ adverse effects
Hemodynamics
Hospital Mortality
Humans
Male
Middle Aged
Postoperative Complications
/ diagnostic imaging
Reoperation
Retrospective Studies
Risk Factors
Time Factors
Transcatheter Aortic Valve Replacement
/ adverse effects
Treatment Outcome
Trans-catheter aortic valve replacement (TAVR)
aortic surgery
aortic valve replacement (AVR)
re-do surgery
Journal
Open heart
ISSN: 2053-3624
Titre abrégé: Open Heart
Pays: England
ID NLM: 101631219
Informations de publication
Date de publication:
2020
2020
Historique:
received:
15
11
2019
revised:
28
01
2020
accepted:
17
02
2020
entrez:
24
3
2020
pubmed:
24
3
2020
medline:
24
3
2020
Statut:
epublish
Résumé
Re-do aortic valve surgery carries a higher mortality and morbidity compared with first time aortic valve replacement (AVR) and often requires concomitant complex procedures. Transcatheter aortic valve replacement (TAVR) is an option for selective patients. The aim of this study is to present our experience with re-do aortic valve procedures and give an insight into the characteristics of these patients and their outcomes. Retrospective review of 80 consecutive re-do aortic valve procedures. Mean patients' age was 51.80±18.73 years. Aortic regurgitation (AR) was present in 51 (65.4%) patients and aortic stenosis (AS) in 38 (48.7%). Indications for reoperation were: infective endocarditis (IE) (23.8%), bioprosthetic degeneration (12.5%), mechanical valve dysfunction (5%), paravalvular leak (6.2%), patient-prosthesis mismatch (3.8%), native valve disease (25%), aortic aneurysm, pseudoaneurysm and dissection (35%), aortic root/homograft degeneration (27.5%). Forty-one (51.2%) patients underwent re-do AVR, 39 (48.8%) re-do complex aortic valve surgery (28 root, 23 ascending aorta and 6 hemiarch procedures) and 37.5% concomitant procedures. A bioprosthesis was implanted in 43.8%, a mechanical valve in 37.5%, a composite graft in 2.5%, a Biovalsalva graft in 6.2% and a homograft in 10% of patients. In-hospital mortality was 3.8% and incidence of major complications was low. A significant proportion of patients were young (61%<60 y), required complex aortic procedures (49%) or presented with contraindications for TAVR (mechanical valve, AR, IE, proximal aortic disease, need for concomitant surgery). Re-do aortic surgery remains the only treatment for such challenging cases and can be performed with acceptable mortality and morbidity in a specialised aortic centre.
Identifiants
pubmed: 32201590
doi: 10.1136/openhrt-2019-001209
pii: openhrt-2019-001209
pmc: PMC7076261
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e001209Informations de copyright
© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Ann Thorac Surg. 2010 Aug;90(2):555-60
pubmed: 20667349
J Thorac Cardiovasc Surg. 2008 Feb;135(2):316-23, 323.e1-6
pubmed: 18242260
Ann Thorac Surg. 2011 Sep;92(3):898-903
pubmed: 21871275
Eur Heart J. 2017 Sep 21;38(36):2739-2791
pubmed: 28886619
Ann Thorac Surg. 2012 Sep;94(3):778-84
pubmed: 22818963
Ann Thorac Surg. 2015 May;99(5):1601-8; discussion 1608-9
pubmed: 25754965
PLoS One. 2013;8(3):e57713
pubmed: 23469220
Eur J Cardiothorac Surg. 2017 Feb 1;51(2):347-353
pubmed: 28186293
Eur J Cardiothorac Surg. 2018 Mar 1;53(3):495-504
pubmed: 29029105
Interact Cardiovasc Thorac Surg. 2012 Jul;15(1):63-8
pubmed: 22493099
Ann Thorac Surg. 2018 May;105(5):1322-1329
pubmed: 29253463
Eur J Cardiothorac Surg. 2015 Feb;47(2):269-80; discussion 280
pubmed: 24686001
Eur J Cardiothorac Surg. 2015 May;47(5):819-23
pubmed: 25009210
Ann Thorac Surg. 2015 Oct;100(4):1298-304; discussion 1304
pubmed: 26209480